Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Study Assessing Immunogenicity and Safety of IC43 In Intensive Care Patients

This study has been completed.
Information provided by (Responsible Party):
Valneva Austria GmbH Identifier:
First received: April 3, 2009
Last updated: October 18, 2012
Last verified: October 2012